Jonathan Irish Archives
Vanderbilt team tracks cellular and antibody responses to COVID-19 vaccine
Jul. 20, 2022—In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.
Looking beyond the ‘magic bullet’ approach to drug discovery
May. 1, 2018—Vanderbilt scientists have developed a new process that can rapidly and inexpensively identify personalized cancer drugs derived from nature.
Investigators seek new way to define cell identity
Mar. 2, 2017—Vanderbilt researchers hope their new method to describe cells will be widely adopted and used to generate a “Who’s Who” database of cell types.
Single-cell analysis of solid tumors
Dec. 12, 2016—A new method will make it possible to study solid tumors and healthy tissues using mass cytometry.
